MoneyWorks4Me

SMS Pharmaceuticals - Quaterly Results

29 May 2024 Evaluate
The Turnover for the quarter ended March 2024 of Rs. 2457.98 millions increase by 64.49% from Rs. 1494.26 millions.Net profit surges 97.19% to Rs. 159.23  millions  from Rs. 80.75 millions in the quarter ended March 2024.Operating profit surged to 351.33 millions from the corresponding previous quarter of 245.03 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 2457.98 1494.26 64.49 7092.63 5220.51 35.86 7092.63 5220.51 35.86
Other Income 16.46 12.56 31.05 44.60 49.14 -9.24 44.60 49.14 -9.24
PBIDT 351.33 245.03 43.38 1213.04 595.88 103.57 1213.04 595.88 103.57
Interest 56.09 58.85 -4.69 234.57 219.13 7.05 234.57 219.13 7.05
PBDT 295.24 186.18 58.58 978.47 376.75 159.71 978.47 376.75 159.71
Depreciation 79.16 79.75 -0.74 315.16 321.25 -1.90 315.16 321.25 -1.90
PBT 216.08 106.43 103.03 663.31 55.50 1095.15 663.31 55.50 1095.15
TAX 56.85 25.68 121.38 169.07 14.65 1054.06 169.07 14.65 1054.06
Deferred Tax 10.55 25.13 -58.02 17.79 14.69 21.10 17.79 14.69 21.10
PAT 159.23 80.75 97.19 494.24 40.85 1109.89 494.24 40.85 1109.89
Equity 84.65 84.65 0.00 84.65 84.65 0.00 84.65 84.65 0.00
PBIDTM(%) 14.29 16.40 -12.84 17.10 11.41 49.84 17.10 11.41 49.84
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..